B
BioMotiv
AcceleratorQuietBioMotiv is a therapeutic accelerator developing a portfolio of novel medicines.
4
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for BioMotiv.
Investment Thesis & Strategy
BioMotiv invests in various stages of biotech, life science, healthcare, and therapeutics companies, specifically focusing on developing novel medicines. They seek to accelerate the development of promising therapeutic candidates.
Investment Activity
Deals per year over the last 8 years
5
20161
20170
20181
20190
20201
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 4 companies
C
Cellusion
Biotech · Growth, 2023
O
Obsidio Therapeutics
Biotech · Growth, 2021
A
Aegle Therapeutics
Biotech · Growth, 2019
I
ImmuNext
Biotech · Growth, 2017
C
CardioKinetix
Biotech · Growth, 2016
N
NeuroVia
Biotech · Growth, 2016
A
Athersys
Biotech · Growth, 2016
R
RenovoRx
Biotech · Growth, 2016
T
T3 Therapeutics
Biotech · Growth, 2016
Frequently Asked Questions
BioMotiv focuses on Pre-seed, Seed stage investments.